Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.

(Courtesy GSK) GlaxoSmithKline appointed Emma Walmsley, the head of its consumer business, to become its next chief executive. She is the first woman to run a major pharmaceutical giant....

Dame Emma Walmsley | Chief Executive Officer Emma joined the Board as CEO Designate on 1 January 2017 and became CEO on 1 April 2017. She has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare.

Jan 23, 2021 · On 1 st April 2017, the GSK Board of Directors made the decision to appoint Emma Walmsley as the first female CEO in the 300-year history of GSK. By many key stakeholders, it was recognised as a controversial decision, inconsistent with GSK and common practices in the UK.

Apr 21, 2023 · Headlining exciting innovation in the pharmaceutical world, Dame Emma Walmsley has been the CEO of GSK since 2017, making her the first woman to run a major pharmaceutical company. Due to her overwhelming insight and experience, in 2020, she was appointed Dame Commander of the British Empire for services to the pharmaceutical industry and business.

May 21, 2024 · When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.

Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work is starting to pay off. Much credit goes to Arexvy, GSK’s...

Dec 6, 2023 · Walmsley is spearheading the transformation, putting new leadership at the head of GSK’s research and development team.

Emma Walmsley is CEO of GSK, a global biopharma company. Before being appointed as GSK’s CEO in 2017, Emma was the CEO of GSK Consumer Healthcare, a joint venture between GSK and Novartis, from its creation in March 2015.